<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR32072</article-id>
      <title-group>
        <article-title>Synthesis and Antimicrobial Evaluation of some novel 2, 3, 7-Trisubstituted Quinazolinones derivatives</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dave</surname>
            <given-names>Rajendra S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Odedara</surname>
            <given-names>Rajendra J.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kalaria</surname>
            <given-names>Rushit I.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Upadhyay</surname>
            <given-names>Jatin J.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2013-04-01">
        <month>04</month>
        <day>01</day>
        <year>2013</year>
      </pub-date>
      <volume>3</volume>
      <issue>2</issue>
      <abstract>
        <p>Reaction of 4-chloro anthranilic acid 1 with chloroacetyl chloride followed by 4-fluoro aniline provides 7-chloro-2-(chloromethyl)-3-(4-fluorophenyl) quinazolin-4(3H)-one 3, which on treatment with 2-chloro benzimidazole in the presence of potassium carbonate yielded 7-chloro-2-(2-chloro-benzoimidazol-1-ylmethyl)-3-(4-fluorophenyl)-3H-quinazolin-4-one 4. The latter on reaction with nitrogen nucleophiles in acetone containing K2CO3 and catalytic amount of KI gave novel 7-Chloro-3-(4-fluoro phenyl)-2-((substituted amino -1H-benz[d]imidazol-1-yl)methyl) quinazolin-4(3H)-one derivatives 5a-h. Furthermore all the compounds were also tested against Gram negative, Gram positive bacteria and fungi. Among the compound tested in this study, compounds 2-(2-pyrrolidin-1-yl-benzimidazol-1-ylmethyl)-3H-quinazolin-4-one (5b) and 2-(2-piperidin-1-yl-benzimidazol-1-ylmethyl)-3H-quinazolin-4-one (5c) found more potent against S. aureus and E. coli compare to reference standard ampicillin.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Quinazolin-4(3H)-one</kwd>
        <kwd>nucleophilic substitution</kwd>
        <kwd>antibacterial activity</kwd>
        <kwd>antifungal activity.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
